GlassScriptPhysician profile
Ashley Miller
NPI 1831642040
$2,688.84
in general payments reported to CMS, 2019-2025
18 companies · $588 in 2025
The $588 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $282 · 2022: $244 · 2023: $238 · 2024: $1,336 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,885 · Travel and Lodging: $233 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,884.79 |
| Travel and Lodging | $232.76 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,077.58 | 2024-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Collegium Pharmaceutical, INC. | $472.66 | 2023-2025 | Belbuca, Xtampza |
| Abbvie INC. | $276.92 | 2021-2025 | |
| Exeltis, USA INC. | $143.18 | 2021-2023 | Slynd |
| Antares Pharma, INC. | $141.96 | 2022-2023 | Xyosted, Nocdurna, Tlando |
| Vertex Pharmaceuticals Incorporated | $132.17 | 2024-2025 | |
| Spr Therapeutics, INC | $70.89 | 2024-2025 | Sprint Pns System |
| Tersera Therapeutics LLC | $69.78 | 2024 | Prialt |
| Ibsa Pharma INC. | $66.90 | 2023-2024 | Tirosint, Licart, Licart |
| Si-Bone, INC. | $48.41 | 2024-2025 | |
| Evofem Biosciences, INC. | $42.69 | 2021 | |
| Nalu Medical, INC. | $42.09 | 2023-2024 | Nalu Neurostimulation System |
| Protega Pharmaceutials INC | $30.73 | 2025 | Roxybond |
| Boston Scientific Corporation | $16.58 | 2024 | |
| Viiv Healthcare Company | $14.84 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $14.27 | 2021 | |
| Scynexis, INC. | $14.06 | 2022 | |
| Pfizer INC. | $13.13 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.